An atypical orthologue of 6-pyruvoyltetrahydropterin synthase can provide the missing link in the folate biosynthesis pathway of malaria parasites by Dittrich, S et al.
An atypical orthologue of 6-pyruvoyltetrahydropterin
synthase can provide the missing link in the folate
biosynthesis pathway of malaria parasites
Sabine Dittrich, Sarah L. Mitchell,
Andrew M. Blagborough,† Qi Wang, Ping Wang,
Paul F. G. Sims and John E. Hyde*
Manchester Interdisciplinary Biocentre, Faculty of Life
Sciences, University of Manchester, 131 Princess
Street, Manchester M1 7DN, UK.
Summary
Folate metabolism in malaria parasites is a long-
standing, clinical target for chemotherapy and prophy-
laxis. However, despite determination of the complete
genome sequence of the lethal species Plasmodium
falciparum, the pathway of de novo folate biosynthesis
remains incomplete, as no candidate gene for dihydro-
neopterin aldolase (DHNA) could be identified. This
enzyme catalyses the third step in the well-charact-
erized pathway of plants, bacteria, and those eukary-
otic microorganisms capable of synthesizing their
own folate. Utilizing bioinformatics searches based on
both primary and higher protein structures, together
with biochemical assays, we demonstrate that P. falci-
parum cell extracts lack detectable DHNA activity, but
that the parasite possesses an unusual orthologue of
6-pyruvoyltetrahydropterin synthase (PTPS), which
simultaneously gives rise to two products in compa-
rable amounts, the predominant of which is
6-hydroxymethyl-7,8-dihydropterin, the substrate for
the fourth step in folate biosynthesis (catalysed by
6-hydroxymethyl-7,8-dihydropterin pyrophosphoki-
nase; PPPK). This can provide a bypass for the
missing DHNAactivity and thus a means of completing
the biosynthetic pathway from GTP to dihydrofolate.
Supported by site-directed mutagenesis experiments,
we ascribe the novel catalytic activity of the malarial
PTPS to a Cys to Glu change at its active site relative to
all previously characterized PTPS molecules, includ-
ing that of the human host.
Introduction
Folate cofactors are essential molecules for all living
organisms, required for the transfer of one-carbon units in
a number of metabolic steps, including the key methylation
of dUMP to give dTMP, an essential nucleotide for DNA
synthesis. Most microorganisms can synthesize the
required folates from the simple precursors GTP,
p-aminobenzoate (pABA) and glutamate. Higher eukary-
otes, with the exception of plants, are incapable of this and
depend on a dietary intake of folate. Drugs targeting folate
metabolism have long been used as highly successful
antimicrobial and anticancer agents (Nzila et al., 2005).
The lethal human malaria parasite, Plasmodium falci-
parum, is capable of both de novo folate biosynthesis and
salvage of pre-formed folate from the plasma of its human
host, as demonstrated by radiolabelling studies with folate
precursors and intact folates (Krungkrai et al., 1989; Wang
et al., 2004a,b). Current evidence suggests that both
routes are essential for sustained healthy parasite growth,
although the reasons for this are unclear (Hyde, 2005). In
other microorganisms (Bermingham and Derrick, 2002)
and in plants (Cossins and Chen, 1997), the enzymic steps
in the folate biosynthetic pathway are well established from
decades of biochemical and genetic analysis. The purine
ring system of GTP is rearranged by GTP cyclohydrolase I
(GTPCH-I; EC 3.5.4.16) to that of a pterin (7,8-
dihydroneopterin triphosphate; DHNTP), the three-carbon
side-chain of which is subsequently cleaved to leave one
carbon atom, after which pABA and glutamate are linked to
the resulting pterin (6-hydroxymethyl-7,8 dihydropterin;
6HMDP) in successive steps involving 6-hydroxymethyl-
7,8-dihydropterin pyrophosphokinase (PPPK or HPPK; EC
2.7.6.3), dihydropteroate synthase (DHPS; EC 2.5.1.15)
and dihydrofolate synthase (DHFS; EC 6.3.2.12) [Fig. 1,
scheme (a)]. However, a long-standing mystery concern-
ing this pathway in P. falciparum is the apparent lack of a
gene encoding the enzyme required for the third step in this
pathway, dihydroneopterin aldolase (DHNA; EC 4.1.2.25),
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the protein that removes two carbon atoms from the pterin
side-chain as described above [Fig. 1, reaction (d) (i)–(ii)].
In contrast to the situation with all other folate biosynthetic
pathway genes in P. falciparum (Brooks et al., 1994; Triglia
and Cowman, 1994; Lee et al., 2001; Salcedo et al., 2001),
our attempts to clone a malarial dhna gene by degenerate
oligonucleotide PCR based on conserved amino acid
motifs in orthologues from other species were unsuccess-
ful, and originally ascribed to low levels of conservation
among such orthologues (e.g. Escherichia coli, Bacillus
subtilis, Pneumocystis carinii and Arabidopsis thaliana
DHNAs share identities of only c. 20–30%, with no contigu-
ous sequences of conserved residues). However, upon
subsequent completion of the genome sequence of P. fal-
ciparum, no dhna gene was apparent by BLAST searches
(Gardner et al., 2002a), nor has one been identified by
similar analyses in other species of Plasmodium or in the
related apicomplexan parasite Toxoplasma gondii that
have been sequenced more recently. We therefore
adopted several strategies, using both bioinformatics and
biochemical assays, to further explore this observation and
to identify how malaria parasites might cope with this
apparent gap in their folate biosynthetic machinery. The
results from such experiments demonstrate that P. falci-
parum possesses a thus-far unique variant of an enzyme
associated in other organisms with the biosynthesis of
tetrahydrobiopterin, which, via a novel mechanism involv-
ing a key amino acid alteration in the active site, can
provide a bypass route to the substrate of the subsequent
enzyme (PPPK) in the folate pathway.
Results
Bioinformatic searches for DHNA
Consistent with the initial analysis of the complete
genome sequence of P. falciparum (Gardner et al.,
2002a), we found that PSI-BLAST (Altschul et al., 1997),
PRATT (Jonassen et al., 1995) and similar search algo-
rithms applied to the predicted complete proteome of
P. falciparum failed to identify any statistically significant
hits for a candidate DHNA enzyme. We therefore
employed more powerful bioinformatics approaches
based on secondary and tertiary structural queries using
the programs 3D-PSSM (Kelley et al., 2000) and GEN-
THREADER (GT) (McGuffin and Jones, 2003), which utilize
different algorithms to predict structural analogues of a
query sequence. This strategy exploited the fact that all
Fig. 1. The conventional folate (a) and biopterin (b) biosynthetic pathways as found in (a) plants, bacteria and lower eukaryotes that are
capable of de novo folate synthesis, and (b) in mammals and other organisms that utilize 5,6,7,8-tetrahydrobiopterin (BH4) as a cofactor.
Certain organisms, such as some fungi, cyanobacteria and pseudomonads, possess both pathways. Pathway (c) involving the P. falciparum
PTPS orthologue is demonstrated in this work and (d) shows the substrates (i), (iii) and products (ii), (iv) of conventional DHNA and PTPS
enzymes respectively. Underlined product (ii) in pathways (a) and (c) is 6-hydroxymethyl-7,8-dihydropterin (6HMDP), the required substrate for
PPPK. Asterisked product (iv) in pathway (c) was identified from its oxidation product (see text). Abbreviations: GTPC, GTP cyclohydrolase I;
P, poorly defined phosphatase activity (thought in some systems to first involve loss of pyrophosphate then subsequent removal of the final
phosphate); DHNA, dihydroneopterin aldolase; PPPK, hydroxymethyldihydropterin pyrophosphokinase; DHPS, dihydropteroate synthase;
DHFS, dihydrofolate synthase; PTPS, pyruvoyltetrahydropterin synthase; SR, sepiapterin reductase.
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DHNAs with determined three-dimensional crystal struc-
tures are members of a small family known as ‘tunnelling-
fold’ (T-fold) proteins (Colloc’h et al., 2000), established
members of which are DHNA, GTPCH-I, urate oxidase
(UO; EC 1.7.3.3), 6-pyruvoyltetrahydropterin synthase
(PTPS; EC 4.2.3.12) and dihydroneopterin triphosphate
epimerase (no EC number assigned) (Colloc’h et al.,
2002). All protein sequences longer than 50 amino acids
(5893 sequences) predicted from the whole genome
sequence by GlimmerM (Salzberg et al., 1999; Gardner
et al., 2002b), developed for identifying coding sequences
in P. falciparum, were processed through 3D-PSSM and
GT. Both identified unambiguously only two T-fold proteins
in the parasite, GTPCH-I (3D-PSSM ‘expect’ value
1.33 ¥ 10-4; GT ‘probability’ value 4 ¥ 10-8) and a putative
PTPS (values of 2.19 ¥ 10-12 and 4 ¥ 10-5 respectively)
(Table 1). All other predicted proteins scored  1.18 in
3D-PSSM and > 0.01 in GT. The 35 proteins falling between
1.18 and 20 in 3D-PSSM and the 27 between 0.01 and 0.1
in GT (classed by the latter as ‘low confidence’) were
examined individually, but none was a credible candidate
for a DHNA orthologue. In addition to the statistical scores
returned by the two programs, this conclusion was based
on the absence in any candidate sequence of a Gxxxx-
ExxxxQ or closely related motif, found near the N-
terminus in all known DHNAs (Fig. S1).
Assay for DHNA activity in P. falciparum cell extracts
While strongly indicative of the absence of a DHNA-
encoding gene in P. falciparum, the above bioinformatic
methods all depend on a degree of similarity at the
primary or secondary structural level. We therefore
assayed for DHNA activity biochemically in P. falciparum
cell extracts without any assumptions as to the possible
nature of the protein. We initially coupled this reaction,
using 7,8-dihydroneopterin (DHN) as the (normal) sub-
strate, to the subsequent two enzymes (i.e. catalysing the
fourth and fifth steps) in the folate biosynthetic pathway,
PPPK and DHPS, in the form of the bifunctional PPPK-
DHPS molecule cloned from T. gondii (Pashley et al.,
1997), and monitored the production of radiolabelled 7,8-
dihydropteroate from [14C] pABA [see Fig. S2, reaction
scheme (a)]. This coupling strategy avoided the need for
custom synthesis of labelled DHN for a direct assay. The
protocol was verified using endogenous DHNA in extracts
of a standard E. coli strain [BL21(DE3)] as a positive
control. To establish that extracts from P. falciparum cul-
tures were generally active for known enzymes, they were
assayed in parallel for both endogenous PPPK-DHPS
and serine hydroxymethyltransferase (SHMT; EC 2.1.2.1)
activities, the latter by monitoring incorporation of 14C from
labelled serine into 5,10-methylenetetrahydrofolate. As
these activities are all involved in folate metabolism, we
reasoned that if a DHNA were also present, it would be
likely to exhibit a comparable level of activity. However,
despite the expected behaviour of all positive controls,
where we could readily measure the reaction products
in both E. coli and malarial extracts from similar cell
numbers (~2.0 ¥ 109 to 1.0 ¥ 1010), no DHNA activity
could be detected in the latter preparations under the
standard assay conditions used (Table 2).
Table 1. Top six hits using the 3D-PSSM program (Kelley et al., 2000) and searching the entire predicted P. falciparum proteome for putative T-fold
protein types.
Gene locus
in PlasmoDBa
T-fold protein type
with highest match
3D-PSSM
e-valueb
3D-PSSM
rankc Annotation in PlasmoDBa
PFF1360w PTPS 2.19 ¥ 10-12 1 6-Pyruvoyl tetrahydropterin synthase, putative (PTPS)
PFL1155w GTPCH-I 1.33 ¥ 10-4 1 GTP cyclohydrolase I (GTPCH-I)
PFF0955c DHNA 1.18 3 Hypothetical protein (with ribonuclease Rh-like InterPro domain)
PF14_0627 DHNA 1.78 6 Ribosomal protein S3, putative
PFB0420w UO 2.32 4 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
PF10_0105 DHNA 2.50 7 Hypothetical protein (with ribosomal L22 protein InterPro domain)
a. From the Plasmodium sequence database at http://www.plasmodb.org/
b. Matches with e-values greater than 1 are considered not to be statistically significant.
c. Position in structural match table; this indicates whether the P. falciparum protein in question shows better matches to other structural families,
as is the case for all but the top two entries above.
Table 2. Plasmodium falciparum cell extracts have SHMT and
PPPK-DHPS but not DHNA activities.
SHMTa PPPK-DHPSb DHNAb
P. falciparum 4110  100 930  60 ndc
(2.97  0.07) (0.66  0.04) (0)
E. coli 5110  80 3800  60 9830  140
(3.69  0.06) (2.70  0.04) (6.97  0.10)
a. Counts accumulated per 10 ml reaction aliquot after 1 h incubation
and 1 h screen exposure.
b. Counts accumulated per 10 ml reaction aliquot after 10 min incu-
bation and 1 h screen exposure.
c. No detectable counts above background.
All values corrected for counts recorded at time zero, normalized to
equal numbers of cells. Means of three determinations  SD; pmol
equivalents in parentheses.
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Investigation of a putative malarial PTPS orthologue
With both the bioinformatics and biochemical data provid-
ing strong and complementary evidence that a conven-
tional DHNA may be lacking in P. falciparum, we next
explored the possibility that the DHNA step could be
bypassed in malaria parasites, focusing on a protein puta-
tively identified as a PTPS orthologue, which is encoded
at the PFF1360w locus of the genome (http://www.
plasmodb.org). The logical basis for this was twofold.
First, this PTPS orthologue had been identified in the
bioinformatics searches above as the only T-fold family
protein in P. falciparum other than GTPCH-I (Table 1).
Second, PTPS enzymes in other organisms use DHNTP
as substrate, which is closely related to DHN, the sub-
strate of DHNA [Fig. 1, reactions (d) (i)–(ii) and (iii)–(iv)],
although at the primary sequence level, the DHNA and
PTPS families are completely different, with no common
motifs (Figs S1 and 3). In other organisms, including
animals, fungi and certain bacteria, PTPS is the second
enzyme in the pathway of tetrahydrobiopterin (BH4) syn-
thesis, an essential cofactor for aromatic amino acid
hydroxylases, glyceryl-ether monooxygenases and nitric
oxide synthases (Thony et al., 2000). Conventionally,
PTPS converts DHNTP to 6-pyruvoyltetrahydropterin
(PTP), which is then reduced by sepiapterin reductase
(SR; EC 1.1.1.153) to BH4 [Fig. 1, scheme (b)]. Upon
alignment of the putative P. falciparum PTPS with all other
known PTPSs, a high level of conservation was apparent,
including residues known from crystallographic studies of
rat PTPS (Burgisser et al., 1995; Ploom et al., 1999) and
Caenorhabditis elegans PTPS [Protein Data Bank (PDB)
structures 1B66 and 2G64 respectively; http://www.rcsb.
org/pdb/home/home.do] to be determinants for DHNTP
binding (Fig. S3). However, a striking divergence in resi-
dues at the active site was evident (Fig. 2). In particular,
the Cys residue (Cys-38/42/43 in C. elegans/rat/human
PTPS; Fig. S3), which is completely conserved in all other
known PTPSs, is absent from that of P. falciparum, of
other Plasmodium species and of the related apicom-
plexan parasite T. gondii. The side-chain of this key
residue ionizes to form the active nucleophile required
for base-catalysed proton abstraction from the substrate
(Burgisser et al., 1995; Ploom et al., 1999). Structural
modelling using crystallographic data for the P. falciparum
enzyme (PDB structure 1Y13) confirmed spatial differ-
ences between the malarial enzyme and those of other
eukaryotes, and in particular, the presence of a Glu
residue (Glu-38) in the former, closely similar in position
and orientation to the active site Cys in the latter (Fig. 2
and Fig. S4). We thus hypothesized that, because of this
change, the malarial PTPS enzyme may have different
catalytic properties compared with conventional ortho-
logues in other organisms.
Activity of the P. falciparum PTPS orthologue
To test this hypothesis, we cloned the P. falciparum ptps
gene into an E. coli expression system and purified the
His-tagged product to near homogeneity. We then analy-
sed this enzyme, together with His-tagged PTPS
enzymes from E. coli and human as controls, for its ability
to act on the natural substrate DHNTP. Pterin products
were separated on high-performance liquid chromatogra-
phy (HPLC) and monitored by the fluorescence of the
pterin ring, which was oxidized prior to chromatography
by acidic iodine to the fully conjugated form, to enhance
fluorescence (Nichol et al., 1985). Both the bacterial and
human enzymes converted DHNTP to PTP as expected
[an unstable compound that is detected after oxidation
and consequent loss of the side-chain at position 6
as unsubstituted pterin (Woo et al., 2002)]. However, the
predominant peak of fluorescence (Pf1) arising from the
malarial enzyme eluted at the same position as authentic
6-hydroxymethylpterin (the oxidized product of 6HMDP),
together with a less intense, more rapidly eluted peak
(Pf2) that coincided with the pterin derived from the bac-
terial and human enzyme reactions (Fig. 3). Control
experiments using commercial 6HMDP confirmed that
the hydroxymethyl side-chain, unlike the 1′, 2′-dioxopropyl
side-chain of PTP, is stable to the ring oxidation
conditions. Thus, in contrast to human and E. coli PTPS,
which yield only the single expected product, the malarial
Fig. 2. Aligned sequences of PTPS orthologues between the
conserved His residues that co-ordinate the active site Zn2+ ion
(arrows). The active site Cys residue conserved in all
non-apicomplexan enzymes to date is marked by an asterisk above
the sequences; the Glu residue proposed to act as nucleophile
instead of Cys in Plasmodium is marked by an asterisk below (see
also Fig. S3). Accession numbers for non-apicomplexan enzymes:
human, Q03393; rat, P27213; guppy, Q90W95; Drosophila
melanogaster, P48611; Caenorhabditis elegans, O02058;
Escherichia coli, P65870; Synechocystis, Q55798. Gene loci for
malarial sequences (http://www.plasmodb.org): Plasmodium
gallinaceum (BLAST search); Plasmodium berghei, PB000950.03.0;
Plasmodium vivax, Pv114505; Plasmodium falciparum, PFF1360w.
The Toxoplasma gondii sequence was also determined from BLAST
searching (http://www.toxodb.org).
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enzyme gives rise to two different products. Although the
ratios of these products were quite variable from run to
run, by measuring the relative fluorescence intensities of
equal concentrations of the 6-hydroxymethylpterin and
pterin standards (1.72:1), we calculated from a series
of assays (n = 13) that the two products are formed in
broadly similar molar quantities, with the former exhibiting
a slight predominance (1.48  0.68 SD mol of 6-
hydroxymethylpterin to 1 mol of pterin).
Verification of PfPTPS production of 6HMDP by linkage
to PPPK-DHPS reactions
The retention time for 6-hydroxymethylpterin upon HPLC
was well separated from those of other common pterins
under our elution conditions and so was straightforward to
identify. However, to confirm the assignment made for this
slower eluting fluorescent product of the malarial enzyme
from its retention time, we coupled the PTPS reaction
to the PPPK and DHPS activities of both T. gondii
and P. falciparum, as described above for DHNA
[Fig. S2, scheme (b)]. The only known substrate for
PPPK enzymes is 6HMDP (Brown, 1971), and both
P. falciparum (Kasekarn et al., 2004) and T. gondii (Smith,
2006) PPPK have been shown to process this compound
in the normal way. Moreover, testing of a wide range of
other pterins as potential substrates for malarial PPPK
has yielded consistently negative results (S.L. Mitchell
and J.E. Hyde, unpublished). In other organisms, 6HMDP
is produced by DHNA in the third step of the conventional
folate biosynthesis pathway [Fig. 1, scheme (a)]. If the
PTPS orthologue from P. falciparum produces this com-
pound, as the HPLC retention time indicated, then the
product of the final enzyme in the coupled assay, radio-
labelled dihydropteroate, should be detectable. A time-
dependent accumulation of this product was indeed
observed when the PfPTPS reaction was linked to either
T. gondii PPPK-DHPS or the P. falciparum equivalent
[Fig. 4, sample (a)]. In contrast, when PTPS from either
human or E. coli was linked to the PPPK-DHPS assay, no
radioactive product was detected [Fig. 4, samples (b) and
(c)], consistent with their producing only PTP in the con-
ventional reaction, which is not a substrate for PPPK.
To rule out the possibility of any contaminating E. coli
DHNA activity producing 6HMDP from DHN that might be
present as a minor component of our DHNTP prepara-
tions, further control experiments were necessary. First,
non-recombinant E. coli lysate was incubated separately
with equal concentrations of DHN and DHNTP for the
standard period. A high level of DHNA activity was
observed when DHN was provided as substrate, but the
almost complete lack of reaction with DHNTP showed that
< 2.5% of the latter had degraded by complete dephos-
phorylation to DHN [Fig. 5, sample (a)]. As expected,
when recombinant E. coli lysate expressing PfPTPS
was similarly tested, significant product could be made
from both substrates [Fig. 5, sample (b)]. Critically,
however, when affinity chromatography/ion-exchange-
purified PfPTPS from the same lysate was assayed in this
way, product was now only observed with DHNTP as the
substrate [Fig. 5, sample (c)]. Together, these data (i)
demonstrate that essentially all of the activity seen with
DHNTP as substrate can be ascribed to the malarial gene
product and (ii) exclude any contribution of E. coli DHNA
carried over from the bacterial lysate acting on DHN
derived from DHNTP breakdown to the production of
6HMDP in our assays. Thus, of the human, bacterial and
parasite PTPS molecules tested, only the malarial ortho-
logue displays the ability to produce 6HMDP, which it
synthesizes specifically from DHNTP, and can thereby
provide the bypass to PPPK necessitated by the apparent
lack of a DHNA activity in this organism.
Site-directed mutagenesis to explore the role of Glu-38
From the primary sequence (Fig. 2) and structural
(Fig. S4) alignments of the P. falciparum PTPS orthologue
with those of other organisms, we hypothesized that the
substitution of a glutamate residue (Glu-38) in
P. falciparum for the active-site cysteine residue of all
other known PTPS molecules was likely to be a major
Fig. 3. HPLC separation of pterin products arising from the
reactions of the PTPS orthologues from P. falciparum (Pf1 and Pf2;
solid line), E. coli (Ec; dotted line) and human (Hs; short-dashed
line) using the normal substrate dihydroneopterin triphosphate
(DHNTP), followed by oxidation to maximize fluorescence from the
pterin ring system (Nichol et al., 1985). This process converts the
products of the reaction 6-pyruvoyl-5,6,7,8-tetrahydropterin to
pterin, and 6HMDP to 6-hydroxymethylpterin. No substrate
(long-dashed line) and no enzyme (dot-dashed line) controls
showed no fluorescence in these positions. Vertical arrows indicate
the retention times of the pterin and 6-hydroxymethylpterin
standards.
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factor in the novel ability of the malarial enzyme to
produce 6HMDP from DHNTP, particularly as no other
residue in this region has an ionizable side-chain capable
of acting as a nucleophile for base catalysis. To investi-
gate this experimentally, site-directed mutagenesis of the
wild-type Pfptps clone was carried out to give a series of
mutants, Glu38Cys, Glu38Gln and Glu38Leu. The ratio-
nale for these modifications was (i) substitution with the
conventional Cys residue into the active site of the
malarial molecule, (ii) substitution with the closely related
residue (Gln) that retains the polar carbonyl group in the
side-chain, but lacks the acidic proton whose dissociation
renders the side-chain of Glu negatively charged at physi-
ological pH, and (iii) substitution with a completely apolar
side-chain (Leu) of comparable volume to that of Glu. The
three mutant clones expressed soluble recombinant pro-
teins at levels comparable to the wild type in E. coli, and
these products all gave circular dichroic (CD) spectra
closely similar to the wild type and characteristic of prop-
erly folded proteins (data not shown). Purified prepara-
tions of the four PTPS variants were assayed in parallel at
equal concentrations after the standard incubation with
DHNTP as substrate and the pterin products monitored by
their fluorescence after HPLC separation (Fig. 6). As
expected, the Glu38Leu mutant, lacking any nucleophilic
centre in the side-chain, gave no detectable product,
whereas the Glu38Cys mutant gave a clear peak of con-
ventional pterin product, but importantly, no 6HMDP. This
was also observed for the Glu38Gln mutant, albeit at a
significantly reduced level. Only the wild-type enzyme
yielded 6HMDP as well as the pterin peak. These data
demonstrate the critical role of the Glu-38 side-chain in
the production of the PPPK substrate.
Discussion
Most microorganisms (Bermingham and Derrick, 2002)
and plants (Cossins and Chen, 1997) synthesize folate de
novo via a well-defined pathway involving GTPCH-I,
m
Fig. 4. Confirmation of 6HMDP production by the P. falciparum
PTPS (Pf) orthologue, but not by those from human (Hs) and
E. coli (Ec). Products of the PTPS reaction were coupled to the
next two enzymes in the pathway, PPPK and DHPS, in the form of
recombinant bifunctional enzyme from T. gondii, and production of
14C-radiolabelled 7,8-dihydropteroate assayed in triplicate on a
Typhoon imager [see Fig. S2, scheme (b), for the reaction set-up
and more experimental detail]. Top, Typhoon image; bottom, plot of
counts recorded after reaction times up to 45 min and expressed
per 1 ml of reaction mix per hour of Typhoon screen exposure
(mean  SD, relative to zero time); (a) PfPTPS with DHNTP
substrate, (b) HsPTPS with DHNTP substrate, (c) EcPTPS with
DHNTP substrate, (d) 6HMDP, (e) no enzyme, but DHNTP
substrate present, (f) PfPTPS, but no substrate present. In the
bottom panel, negative controls (e) and (f) are omitted for clarity.
In the positive control (d), commercial 6HMDP was provided as
substrate for the PPPK step. One hundred counts on the ordinate
are equivalent to 0.071 pmol product per ml of reaction mix.
Qualitatively similar results were obtained when P. falciparum
PPPK-DHPS was used in the coupled reaction instead of T. gondii
PPPK-DHPS.
m
Fig. 5. Formation of 14C-radiolabelled 7,8-dihydropteroate starting
from either DHNTP (black) or DHN (grey) substrate (20 mM, 1 h
incubation, 37°C) as recorded on the Typhoon imager (per 1 h
screen exposure) from comparable amounts of (a) lysate from
untransformed E. coli cells (and thus containing only EcDHNA)
and (b) lysate from transformed E. coli cells overexpressing
PfPTPS. The same experiment is repeated in (c) using affinity
chromatography/ion-exchange-purified PfPTPS obtained from an
equal volume of lysate as used in (b). One hundred counts on the
ordinate are equivalent to 0.071 pmol product per ml of reaction
mix.
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DHNA, PPPK, DHPS and DHFS [Fig. 1, scheme (a)]. The
predicted functions of all but one of these enzymes,
DHNA, that are also expected to be present in
P. falciparum, have been confirmed by biochemical
assays on parasite-derived cloned gene products
[GTPCH-I (P. Wang and J.E. Hyde, unpublished); PPPK
(Kasekarn et al., 2004); DHPS (Triglia et al., 1997); DHFS
(Salcedo et al., 2001)]. Here, we were unable to detect
DHNA activity in P. falciparum extracts that were demon-
strably active in other enzymes of folate metabolism,
although we cannot exclude the formal possibility of a
parasite variant that is inactive under our standard assay
conditions, in which DHNA is readily detected from E. coli
lysates. However, these biochemical data are consistent
with the uniformly negative bioinformatic searches for a
DHNA-encoding gene using a range of algorithms that
depend on similarities at either the primary sequence, or
secondary/tertiary structural, levels. With respect to its
component enzymes, P. falciparum is thus unusual in
apparently lacking DHNA in an otherwise complete
pathway that is essentially identical to that found in other
folate-producing organisms. In addition, we demonstrate
that, in the apparent absence of such a gene, the parasite
encodes an unusual member of the PTPS family, which is
a viable alternative to DHNA capable of synthesizing the
6HMDP required as substrate for PPPK from DHNTP.
Moreover, the direct experimental coupling of this reaction
to P. falciparum PPPK-DHPS to produce dihydropteroate
now provides the basis for a complete definition of a
pathway for folate biosynthesis in this organism [Fig. 1,
scheme (c)]. We also note that deployment of the PfPTPS
orthologue in the synthesis of 6HMDP would eliminate the
need for a separate phosphatase activity to act on
DHNTP, as depicted in the second step of the conven-
tional pathway in Fig. 1, scheme (a). Microarray analyses
(Llinas et al., 2006) show that the gene encoding PfPTPS
(PFF1360w) is expressed across the blood stages of all
parasite lines investigated with a shallow peak at 18–22 h
post invasion, corresponding to the early to mid-
trophozoite stages. This resembles the patterns seen for
the other folate biosynthesis genes, all of which peak
during the 20–30 h phase of the 48 h asexual cycle (http://
www.plasmodb.org and Nirmalan et al., 2002; Llinas
et al., 2006). Interestingly, not only is PfPTPS capable of
providing the PPPK substrate, it simultaneously gener-
ates a comparable amount of the normal PTP product of
this class of enzyme, at least under our in vitro conditions.
This suggests a possible dual role for PTPS in parasite
pterin metabolism, and may relate to the discovery of a
P. falciparum pterin 4a-carbinolamine dehydratase (PCD;
EC 4.2.1.96) with conventional pterin recycling activity
(Wang et al., 2006). However, such a second role for
PfPTPS may not lie in the standard BH4 synthesis
pathway [Fig. 1, scheme (b)] because we detect little or
no BH4 in parasite extracts, whereas 6HMDP is readily
observed (P. Wang and J.E. Hyde, unpublished).
Despite significant primary sequence variation, all bac-
terial and eukaryotic PTPSs characterized to date pre-
serve the key Cys residue in their active sites (Fig. 2), and
we show here that, unlike the malarial enzyme, neither
E. coli nor human PTPS is capable of producing 6HMDP
from DHNTP (Figs 3 and 4). We ascribe this reaction to
the replacement in P. falciparum of the Cys residue with
Glu-38, whose side-chains in our models occupy a very
similar spatial position and orientation relative to the
active site (Fig. S4). That substitution of Glu-38 for Cys
is the critical evolutionary modification of the malarial
enzyme is strongly supported by our site-directed
mutagenesis experiments, where reverse engineering of
the wild-type PfPTPS to place Cys in the active site abol-
ishes the production of 6HMDP and causes the enzyme to
behave as a conventional PTPS molecule (Fig. 6). The
shift to a Glu residue in the natural malarial enzyme
replaces the single nucleophilic centre of Cys with nega-
tive charge distributed over the two side-chain oxygens of
Glu, which could explain our observation of two products
generated in comparable quantities by the parasite
orthologue (see Fig. S5 and legend for a proposed
mechanism). This hypothesis could be explored further by
crystallography of the wild type and three mutant versions
of PfPTPS with bound substrate/product or analogues,
which would also extend the only structural data of
Fig. 6. Effect of mutation of the Glu-38 residue in the
P. falciparum PTPS orthologue on the reaction products. HPLC
separated pterin products arising from the reactions of the wild type
(solid line), E38C variant (dashed line), E38Q variant (dotted line)
and E38L variant (dot-dashed line) using dihydroneopterin
triphosphate (DHNTP) as substrate, followed by processing and
calibration as for Fig. 3.
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PfPTPS currently available, where the wild-type enzyme
is bound to biopterin in PDB structure 1Y13.
A previous study has indicated that disruption of the
folate biosynthetic pathway by gene deletion in this
haploid organism is apparently lethal, even in the pres-
ence of exogenous (salvageable) folate, and thus unlikely
to be a feasible route to confirm the in vivo role of PfPTPS
in this pathway (Wang et al., 2004b). Moreover, no spe-
cific inhibitors of PTPS molecules have yet been reported
that could be utilized to this end. However, the bioinfor-
matic and biochemical evidence we report here is consis-
tent with the absence of a conventional DHNA activity,
while revealing the presence of an unusual apicomplexan
PTPS orthologue whose product provides the necessary
substrate for PPPK. This suggests that P. falciparum and
related parasite species have evolved a novel and unex-
pected route of folate biosynthesis and that the structural
and biochemical differences between the malarial and
mammalian PTPS orthologues identified here might be
exploitable in the search for new parasite targets within
this critical pathway. However, given the major importance
of the BH4 synthesis pathway in humans, any candidate
inhibitors would need to show a marked discrimination
between the host and parasite molecules.
Experimental procedures
DHNA, PPPK, DHPS and SHMT activities
DHPS activity was measured by the incorporation of [ring-14C]
pABA into DHP, as previously described (Aspinall et al.,
2002); DHNA and PPPK were monitored by coupling their
activities to that of DHPS, using the appropriate substrates:
6HMDP for PPPK activity and 7,8-dihydroneopterin for DHNA
activity (Schircks, Switzerland) [Fig. S2, scheme (a)]. Stan-
dard reactions (100 ml) contained 20 mM pterin substrate,
0.1 M Tris-HCl (pH 8.0), 5 mM DTT, 10 mM MgCl2, 20 mM
ATP (for DHNA and PPPK activities), 20 mM [14C] pABA (spe-
cific activity 58 mCi mmol-1; Moravek, California) and
enzyme. To couple the DHNA reaction, mixes were supple-
mented with 2 mg of recombinant PPPK-DHPS from T. gondii
(Aspinall et al., 2002) or from P. falciparum (Triglia et al.,
1997), as appropriate. The reaction was incubated at 37°C
for 1 h, together with negative controls lacking either enzyme
or substrate. Aliquots (25 ml) were removed and reactions
stopped by EDTA added to 2.5 mM. Aliquots were then
spotted onto DE-81 paper (Whatman, UK) pre-soaked in
2.5 mM EDTA (pH 8.0) and air-dried. Unincorporated [14C]
pABA was removed by washing for 1 h in 80 mM NaCl, 0.1 M
Tris-HCl (pH 7.9) at room temperature (3 ¥ 500 ml). The
radioactivity incorporated into [14C] DHP on the dried paper
was detected on a Typhoon scanner (Amersham, UK)
after ~24 h exposure. Counts were quantified using the
ImageQuant program and corrected for background counts
seen in negative controls and thus are expressed as absolute
product counts. SHMT activity was measured by incorpora-
tion of 14C from serine to 5,10-methylenetetrahydrofolate
using a modified protocol (Smith, 2006) based on Geller
and Kotb (1989). The assay mixture (100 ml) contained
50 mM Tris-HCl (pH 8.0), 3 mM DDT, 0.25 mM pyridoxal
5′-phosphate (Sigma, UK), 2.5 mM EDTA, 2 mM tetrahydro-
folate (Schircks, Switzerland), 0.024 mM [3-14C] serine
(57 mCi mmol-1, Moravek, CA), 0.2 mM unlabelled serine
and enzyme, and radiolabelled product counts determined as
above, except that the chromatography paper was washed
in running dH2O for 2 h to remove unconverted 14C-serine.
Counts detected in this way were converted to picomoles of
product by comparison with standard curves generated by
directly imaging known quantities of the radiolabelled sub-
strates and assuming equimolar conversion to product during
the enzyme reactions.
Cell extracts
Plasmodium falciparum-infected erythrocytes were saponin-
lysed and the harvested parasite pellets (~1–5 ¥ 1010 para-
sites) re-suspended in 500 ml of Reporter Gene Lysis Buffer
in the presence of Complete C Protease Inhibitor Cocktail,
1 U DNase and 1 U RNase (all reagents from Roche, Swit-
zerland) and incubated at room temperature with gentle agi-
tation for 15 min. The resultant lysates were centrifuged
(14 000 g, 30 min) at 4°C and the soluble fraction decanted
and concentrated to 200 ml, from which 40 ml was used per
assay. E. coli pellets from cultures of known density were
lysed using BugBuster detergent (Novagen, UK) according to
the manufacturer’s guidelines in the presence of Complete C
Protease Inhibitor Cocktail, 1 U DNase and 1 U RNase. The
soluble fraction was decanted into a fresh tube after centrifu-
gation and reduced to 1/50 of the volume of initial culture,
from which 40 ml was used per assay.
Cloning and expression of the P. falciparum ptps gene
The intronless ptps gene from P. falciparum genomic DNA
(K1 strain) was PCR amplified using primers tailored to the
Ek/LIC (Novagen) expression system: GACGACGACAA-
GATGATGAAAGAGGAAACCCTAAATTCAG (forward) and
GAGGAGAAGCCCGGTTTATATATATTTGTGGACTATGGCC
TTTTGTG (reverse). The PCR product was extracted after
gel separation using Zymoclean (Zymo Research, USA) and
cloned into the pET-46 Ek/LIC vector (Novagen, UK) to
produce the plasmid Pfptps-pET46 by ligation-independent
cloning using T4 polymerase.
Purification of recombinant PTPS
Escherichia coli strain Rosetta2(DE3)pLysS (Novagen, UK)
was transformed with Pfptps-pET46, induced by 1 mM IPTG
at an OD600 of 0.6–1.0, and the cells were grown for a further
5 h at 30°C, harvested by centrifugation and lysed using
BugBuster (Novagen, UK). The PfPTPS N-terminal His-
tagged fusion protein in the soluble crude extract was purified
by absorption onto a column of Ni-NTA resin (Qiagen, UK),
washing with 20 mM imidazole in 300 mM NaCl, 50 mM
NaH2PO4, pH 8.0, elution with 250 mM imidazole in the same
buffer, dialysis into 100 mM Tris-HCl (pH 8.0), 2 mM DTT and
storage in 10% glycerol at -80°C until further use. His-tagged
PTPSs from E. coli and human were produced in the same
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way from pET-28a-based clones pET-ePTPS and pET-
hPTPS respectively (Woo et al., 2002). Further purification of
the enzyme was carried out on a Resource Q ion exchange
column (GE Healthcare, UK), binding in 50 mM Tris (pH 8.0),
5 mM DTT, 25 mM NaCl, and eluting in the same buffer
except with 1 M NaCl.
Assay of PTPS activity
PTPS activity was assayed according to Lee et al. (1999)
with minor modifications. Assays were performed in 100 mM
Tris-HCl (pH 8.0), 10 mM MgCl2, 9 mM DHNTP, 2 mM DTT
with 1–2 mg ml-1 purified PTPS in a total volume of 50 ml for
1 h at 37°C. The reaction mixture was treated with 100 ml of
acidic iodine solution (2% KI/1% I2 in 1 M HCl) for 1 h in the
dark to oxidize the pterin ring and thereby maximize fluores-
cent intensity (Nichol et al., 1985). After centrifugation,
excess iodine in the supernatant was reduced to iodide by
50 ml of 5% ascorbic acid, the sample passed through a
0.2 mm Micro-Spin filter (Alltech Associates, UK) and 20 ml
analysed for pterins by HPLC on a Dionex Summit system.
A reverse-phase column, Adsorbosil C18, 10 mm,
250 ¥ 4.6 mm internal diameter (Alltech Associates, UK), was
used with a mobile phase of 10 mM sodium phosphate,
pH 6.0, at a flow rate of 1 ml min-1 for 40 min. Fluorescence
excitation and emission wavelengths were set to 350 nm and
450 nm, respectively, and areas under peaks used to calcu-
late product ratios. Retention times were compared with
pterin standards obtained from Schircks, Switzerland. Abso-
lute retention times were critically dependent on the condition
of the column from previous usage, so all samples and stan-
dards for a given experiment were run in immediate
succession.
DHNTP substrate was produced from GTP in a separate
reaction using Synechocystis GTPCH-I as described (Lee
et al., 1999). DHNTP concentration was estimated from its
absorbance at 330 nm using an extinction coefficient of
6300 M-1 cm-1 (Bracher et al., 1998). Aliquots of the DHNTP
reaction mixture were frozen at -80°C and used once for
PTPS enzyme assays. The coupled PTPS-PPPK/DHPS
assay was performed as described above for DHNA assays
with minor modifications [Fig. S2, scheme (b)]. The reaction
(200 ml) was performed in 100 mM Tris-HCl (pH 8.0), 5 mM
DTT, 20 mM DHNTP, 10 mM MgCl2, 20 mM ATP, 20 mM [14C]
pABA, 1 mg ml-1 purified PTPS and 7.5 mg ml-1 TgPPPK/
DHPS or 3 mg ml-1 of concentrated lysate from cells express-
ing PfPPPK/DHPS. Reactions were incubated at 37°C for
1 h. The positive control contained 20 mM 6HMDP (Schircks,
Switzerland) instead of PTPS enzyme and substrate.
Site-directed mutagenesis of the Pfptps gene
Three oligonucleotides were designed to mutate the codon
for Glu-38 in the ‘FRETLH’ motif of the putative active site of
the P. falciparum ptps gene (Fig. 2). GAA (Glu) was mutated
to CTT (Leu) with 5′-TACAATGGTTTTCGActtACCTTAC
ATGGTCATA, to CAG (Gln) with 5′-TACAATGGTTTTCGA
cagACCTTACATGGTCATA and to TGC (Cys) with 5′-TA
CAATGGTTTTCGAtgcACCTTACATGGTCATA. Mutagenesis
was carried out with the GeneEditor in vitro site-directed
mutagenesis system (Promega, UK) on the expression
plasmid PfPTPS-pET46 described above. All inserts were
completely sequenced to verify the desired alterations and
ensure that no others had been introduced.
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